WASHINGTON — A September 29 meeting at the White House may have a major impact on the future of free speech and the Internet. Drug lobbyists are seeking to get ICANN to delete the domain name registrations of companies which do not comply with US law, even if those companies are based overseas and are complying with the laws of their native countries.
Such a move would be nothing less than an existential threat to the Internet and hence to free speech and all of the benefits which the Internet has brought about.
Ostensibly the meeting is to address the matter of importation of pharmaceutical drugs by US residents. Some nations do not require prescriptions for certain drugs, and recently a teenager reportedly overdosed on a painkiller purchased over the Internet.
Most nations impose regulation on pharmaceutical products. The United States remains the most profitable market for drugmakers. As more Americans order drugs from Canada and elsewhere, the drug lobbyist, known as Big Pharma, see a significant long-term threat to the profitability of pharmaceutical manufacturers. A former Bush administration official, John Horton, set up a company while he was still working in the White House, and that company (now known as LegitScript.com) claims to vet websites selling drugs. Horton argues that he didn't actually set up the company until two weeks after he left the administration but rather he only set up domain names for it. Therefore, he was in compliance with federal ethics laws.
The problem is that Horton's major competitor is New York-based PharmacyChecker.com--and the site is not sufficiently restrictive for the tastes of Horton's financial backers. A close examination of Horton's statements as to his financial support leads many to suspect that Big Pharma is the de facto funder of Horton's site via purchasing "research reports" offered for sale by LegitScript.
All of this would not be news to any uninsured American who has followed the debate over importation of pharmaceuticals. And the practice is so common that the US government has an informal understanding that shipments of drugs for personal use not exceeding 90 days supply will not be turned back at the border.
Having failed to get the cooperation of the FDA, the supporters of Big Pharma have now taken another approach. Led by Horton and LegitScript, they have put pressure to take down the websites of companies sending drugs to Americans via certain countries such as Vanuatu. Major drugmakers such as Ciplasupply drugs to intermediaries in Vanuatu, which are then shipped to the United States.
In an interview with Blue MauMau today, Horton denied that he is funded by the pharmaceutical industry.
The meeting at the White House is with representatives of the Internet Corporation for Assigned Names and Numbers, ICANN, a not-for-profit U.S. organization that coordinates unique domain name identifiers across the world. It is the organization that ensures that domain name TacoBell.com is assigned and gets you there, and not to say, DelTaco.com.
For many years, foreign governments have been wary about how much influence the US government exercises over the Internet, and while ICANN and the US government have dismissed such concerns as unwarranted, the September 29 meeting may give new impetus to proposals to set up alternate webs which cannot be controlled by ICANN.
To have a low-level meeting at some agency office is one thing. But any meeting which is scheduled at the White House necessarily sends a message independent of the substantive content of the meeting. And to have the top ICANN officials summoned to discuss taking down internet access to companies which don't dance to the US tune is a remarkable start down a slippery slope.
A PharmacyChecker spokesperson told Blue MauMau that the company is run by a medical doctor. He argues that his firms certification standards are every bit as restrictive as legitscript, except that his firm allows non U.S. pharmacies to be certified.
Apart from the PharmacyChecker letter to the White House (posted on their website) the media has not picked up on this story. This is a story which has rammifications far beyond a few pills dispensed without a prescription. Once the genie is out of the bottle, it may be impossible to put it back.
Web Analytics Training
Amazon.com subsidiary Amazon Technologies, Inc. was today granted U.S. patent number 7,805,379 for “Method and system for leasing or purchasing domain names”.